Sponsored by ArgenTag Corporation (“ArgenTag”) and Oxford Nanopore Technologies, Inc. (“Oxford Nanopore Technologies”), individually referred to as a “Sponsor” and collectively as the “Sponsors”.

​

 

NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO APPLY OR BE SELECTED.

​

 

1. Eligibility

​

Participation in the ArgenTag Single-Cell Isoform-Resolved Long-Read Sequencing Grant Program (the “Grant Program”) is open to individual applicants who:

• Are professionally engaged in laboratory-based scientific research.

• Are at least 18 years of age and have reached the age of majority in their jurisdiction of residence.
   

Employees, officers, directors, agents, representatives, and independent contractors of ArgenTag, Oxford Nanopore Technologies or any of their respective affiliates, as well as members of their immediate families or households (whether related or not), are not eligible to participate.

​

The following individuals and entities are also ineligible:

1. Residents of any country or territory subject to U.S. embargoes or trade restrictions, or where participation would be prohibited by applicable law.

2. Any individuals or entities listed on U.S. government restricted or denied-party lists (including, but not limited to, the Denied Persons List, Specially Designated Nationals List, Entity List, or Unverified List).

3. Any persons or entities for whom participation would be illegal, or with whom the Sponsors are prohibited from conducting business.

 

The Grant Program is void where prohibited by law and is subject to all applicable local, national, and international laws and regulations.

​

2. How to Apply

​

The Grant Program opens on September 22 and closes on October 30 at 11:59 PM Eastern Time. Applications submitted outside this period will not be considered.

​

To apply, applicants must submit the required information via the designated online application form provided by ArgenTag. Applications must include:

​

• Applicant’s full name and email address.

• Institutional affiliation.

• City, state and country.

• Research area selection.

• Information on access to a PromethION sequencing platform, if available. (*) 

• A written project abstract (maximum 500 words).

​

(*) Access to an Oxford Nanopore Technologies PromethION platform is encouraged but not required. Selected applicants who do not have access to a PromethION platform may receive assistance from the Sponsors in arranging access to sequencing services. 

​

By submitting an application, the applicant acknowledges that all submitted materials become the property of the Sponsors and will not be returned. The Sponsors make no guarantee regarding the confidentiality or security of submitted materials.

​

Submission of an application grants Sponsors permission to contact the applicant regarding this Grant Program and related products or services of the Sponsors, whether or not the applicant is selected.

​

3. Selection Process and Notification

​

Grant recipients will be selected by a review panel composed of the Sponsors’ scientific staff and advisors based on the criteria outlined in the Grant Program description, including scientific merit, fit to the technology, feasibility, and willingness to publicly present results.

​

The Sponsors may request additional information or interviews from finalists prior to final selection.

​

Selection decisions are final and binding. Selected applicants will be notified via email within approximately five (5) business days of selection. Failure to respond within the specified time may result in forfeiture of the award and selection of an alternate recipient.

​

The number of awards granted and the likelihood of selection depend on the number and quality of eligible applications received.

​

4. Award Description

 

The Grant Program award may include:

​

• Up to four reactions (~40,000 cells) of the ArgenTag Single-Cell RNA Library Kit for Long-Read Sequencing.

• Oxford Nanopore Technologies’ Ligation Sequencing Kit V14 (SQK-LSK114) and R10.4.1 flow cells.

• Project planning support and a one-hour debrief with ArgenTag’s scientific board.

• Basic bioinformatics analysis covering demultiplexing, barcode/UMI processing, cell calling, quality metrics, and standard visualizations (UMAP).

 

No cash equivalent, substitution, transfer, or assignment of the award is permitted.

​

5. Recipient Obligations and Restrictions

 

Recipients must:

​

• Provide samples and perform experiments in accordance with ArgenTag’s technical guidance

• Obtain all necessary institutional approvals and authorizations.

• Complete the single-cell cDNA generation and library preparation, as well as sequencing and basecalling, by January 31, 2027.

 

Recipients shall provide regular project updates via bi-weekly progress meetings with ArgenTag’s R&D team, from receipt of the reagents until the final debrief meeting. 

 

Recipients agree to acknowledge the Sponsors’ contribution in any public presentations, publications, or communications related to the awarded project, subject to reasonable review and approval by the Sponsors.

 

Recipients may be required to execute an eligibility affidavit, liability release, and publicity release (where permitted by law). Failure to do so may result in forfeiture of the award.

All taxes, fees, and costs associated with use of the award are the sole responsibility of the recipient and/or their institution.

​

6. Use of Name and Publicity

 

Applicants authorize the Sponsors to use the information provided in their application for communications and marketing purposes, as appropriate, provided that no confidential or sensitive information is disclosed.

​

By accepting the award, recipients grant the Sponsors the right to use their name, title, institutional affiliation, project title, general project description, and institution name and logo for promotional and informational purposes, including on the Sponsors’ respective websites, marketing materials, and social media, without additional compensation or prior notice to the recipient.

​

Any use of data generated as part of the Grant Program will require the recipient's prior consent.

​

7. Data, Confidentiality, and Intellectual Property

 

Applicants represent and warrant that submitted materials do not infringe on third-party rights and that they have the authority to disclose the information provided.

​

The Sponsors make no guarantees regarding confidentiality of submissions. Intellectual property arising from the awarded research remains with the recipient unless otherwise agreed in writing.

​

8. Limitation of Liability and Indemnification

 

By participating in the Grant Program, applicants agree to release and hold harmless the Sponsors, their respective directors, officers, employees and independent contractors, and  their respective affiliates and their directors, officers, employees and independent contractors from any liability arising from participation in the Grant Program or use of the award.

​

The Grant Program and award are provided “as is,” without warranty of any kind, express or implied.

​

To the fullest extent permitted by law, neither Sponsor shall have any liability arising from the Grant Program. If liability cannot be excluded, the aggregate liability of each Sponsor shall not exceed the approximate value of the awarded materials of that Sponsor.

​

9. Modification, Suspension, and Termination

 

The Sponsors reserves the right to modify, suspend, or terminate the Grant Program at any time if circumstances arise that compromise the integrity, legality, or administration of the program.

​

10. Governing Law

 

These Official Rules shall be governed by and construed in accordance with the laws of the State of Delaware, USA, without regard to conflict-of-law principles. Any disputes shall be brought exclusively in the appropriate state or federal courts located in Delaware.

​

11. Sponsor’s Details

 

ArgenTag Corporation
7 Pennsylvania Plaza, New York, NY 10001, United States

Oxford Nanopore Technologies, Inc.
101 Avenue of the Americas, New York, NY 10013, United States

​

All products supplied by the Sponsors are provided for research use only and not for use in diagnostic procedures. Recipients shall not use the products in any manner inconsistent with applicable laws, regulations, product documentation or labeling.